Target intelligence / Profile preview

SPRY domain-containing protein 3 (SPRYD3)

Target
SPRYD3
Molecular classification
Other (SPRY domain-containing protein)
01

Overview

SPRY domain-containing protein 3 (SPRYD3) is a member of a family of proteins defined by the presence of a SPRY domain, a conserved sequence module involved in protein–protein interactions[3]. SPRY domains are structural elements originally found in a variety of eukaryotic proteins; their principal function is to mediate binding to other regulatory proteins or to stabilize intramolecular interactions[1][3]. The specific biological function of SPRYD3 is currently unclear, and its interacting partners and involvement in cellular pathways are largely unknown[3]. SPRYD3 is not considered to be a receptor, enzyme, transporter, or other classic therapeutic target class. There are no known drugs, clinical biomarkers, or well-documented disease associations for SPRYD3. Limited evidence suggests SPRYD3 may participate in intracellular signaling via its interaction domain, but no direct links to pathophysiology or clinical applications have been established[3]. The protein does not have a defined role in signal transduction, cell cycle, apoptosis, or major disease roles based on current research.

Other names
SPRYD3FLJ14800SPRY domain containing 3SPRY domain-containing protein 3
02

Biological functions

Protein–protein interactionPossible regulation of signaling pathways (such as Wnt and FGF signaling)Unknown/other
03

Disease associations

Other (no established role in major human diseases; little evidence as a therapeutic target)

Beyond the preview

Go deeper on SPRY domain-containing protein 3 (SPRYD3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPRY domain-containing protein 3 (SPRYD3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call